Therapeutic response and survival time of immunobiologicals in patients with moderate to severe psoriasis
AUTOR(ES)
Mota, Cynthia Cristina Ferreira; Romiti, Ricardo; Arnone, Marcelo; Hirayama, Andre Luís da Silva; Takahashi, Maria Denise Fonseca
FONTE
Anais Brasileiros de Dermatologia
DATA DE PUBLICAÇÃO
2022
RESUMO
Documentos Relacionados
- Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis
- Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme
- Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity,
- Evaluation of the efficacy, safety, and side effects of secukinumab in patients with moderate-to-severe psoriasis: real-world data from a retrospective multicenter study
- Moderate to severe psoriasis treatment challenges through the era of biological drugs